UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

Notice of Effectiveness

Effectiveness Date: November 14, 2025
Accession Number: 0001104659-25-103158
Submission Type: POS AM
CIK: 0001621227
Company Name: Adaptimmune Therapeutics PLC
File Number: 333-286639